Triple-negative breast cancer (TNBC), defined by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), represents the most aggressive subtype of breast cancer (Gajulapalli et al., 2016). The gene discussed is ESR1; the disease is triple-negative breast carcinoma.